Efficacy of Probiotics as Adjuvant to the Standard Triple Therapy for the Treatment of Helicobacter Pylori-Associated Peptic Ulcer Disease: A Randomized-Control Trial

Probiotics are a valuable and well-tolerated adjunct to current H. pylori treatment regimens. This study evaluates the effectiveness of adding probiotics to standard triple therapy (comprising a proton pump inhibitor, clarithromycin, and amoxicillin) for better Helicobacter pylori eradication and treating peptic ulcer condition, compared to triple therapy alone, amidst rising antibiotic resistance.